WHA67

May 2014
Geneva

See A67/1 Rev.1 for agenda

See Secretariat docs page

See WHA67/2014/REC/3 for summary records of debate

See WHA67/2014/REC/1 for decisions, resolutions and annexes

Agenda

1
Opening
1.1
Credentials
1.4
Adoption of agenda and allocation of items to committees
2
Reports from EB133 and 134
3
Address by Dr Margaret Chan, Director-General
4
Invited speakers: Invited speaker (Christine Kaseba-Sata, First Lady of Zambia; Melinda Gates)
11.2
Improved decision-making by the governing bodies
11.3
Framework of engagement with non-state actors
11.4
Follow up to the financing dialogue
11.5
Strategic resource allocation
11.6
Financing of administrative and management costs
12
Communicable disease
12.1
Draft global strategy and targets for tuberculosis prevention, care and control after 2015
12.2
Global vaccine action plan
12.3
Hepatitis
13
Noncommunicable diseases
13.4
Comprehensive and coordinated efforts for the management of autism spectrum disorders
13.5
World psoriasis day
14
Promoting health through the life course
14.3
Addressing the global challenge of violence, in particular against women and girls
14.4
Multisectoral action for a life course approach to healthy ageing
14.5
Public health impacts of exposure to mercury and mercury compounds: the role of WHO and ministries of public health in the implementation of the Minamata Convention
14.6
Contributing to social and economic development: sustainable action across sectors to improve health and health equity
15
Health systems
15.1
Traditional medicine
15.2
Follow-up of the report of the CEWG on R&D: Financing and Coordination
15.3
SFC
15.4
Access to essential medicines
15.5
Strengthening of palliative care as a component of integrated treatment throughout the life course
15.7
Health intervention and technology assessment in support of universal health coverage
15.8
Follow-up of the Recife Political Declaration on Human Resources for Health: renewed commitments towards universal health coverage
16
Preparedness, surveillance and response
16.2
Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits
16.3
Smallpox eradication: destruction of variola virus stocks
16.4
Poliomyelitis: intensification of the global eradication initiative
16.5
Antimicrobial drug resistance
17
Progress reports
18
Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan
20
Programme budget and financial matters
20.1
Programme budget 2012–2013: performance assessment
20.2
Financial report and audited financial statements for the year ended 31 December 2013
20.3
Status of collection of ACs
21
Audit and oversight
21.1
Report of external auditor
21.2
Report of internal auditor
22
Staffing matters
22.1
Human resources: annual report
22.2
Report of International Civil Service Commission
22.3
Amendments to the Staffing Regulations and Rules
22.4
Appointment of representatives to the WHO Staff Pension Committee
23
Management and legal matters
23.1
Follow-up of the report of the Working Group on the Election of the Director-General of the World Health Organization
23.2
Real estate: update on the Geneva buildings renovation strategy
24
Collaboration within the United Nations system and with other intergovernmental organizations